881681-33-0

Basic information

• Product Name: 1H-Pyrrole-3-carboxaldehyde, 1-[(3-chlorophenyl)sulfonyl]-4-methyl-5-phenyl-
• CAS NO: 881681-33-0
• Molecular Formula: C18H14ClNO3S
• Molecular Weight: 359.833
• Mol File: 881681-33-0.mol
• Article Data: 2

Chemical Properties

• CAS DataBase Reference: 1H-Pyrrole-3-carboxaldehyde, 1-[(3-chlorophenyl)sulfonyl]-4-methyl-5-phenyl-(CAS DataBase Reference)
• NIST Chemistry Reference: 1H-Pyrrole-3-carboxaldehyde, 1-[(3-chlorophenyl)sulfonyl]-4-methyl-5-phenyl-(881681-33-0)
• EPA Substance Registry System: 1H-Pyrrole-3-carboxaldehyde, 1-[(3-chlorophenyl)sulfonyl]-4-methyl-5-phenyl-(881681-33-0)

Safety Data

• Hazardous Substances Data: 881681-33-0(Hazardous Substances Data)

Upstream product

• 2888-06-4 3-chlorophenylsulfonyl chloride 
• 881675-51-0 methyl 1-[(3-chlorophenyl)sulfonyl]-4-methyl-5-phenyl-1H-pyrrole-3-carboxylate 
• 881674-89-1 methyl 5-bromo-1-[(3-chlorophenyl)sulfonyl]-4-methyl-1H-pyrrole-3-carboxylate 
• 881674-29-9 methyl 5-bromo-4-methyl-1H-pyrrole-3-carboxylate 
• 114615-82-6 tetrapropylammonium perruthennate 

Relevant articles and documents

Proton pump inhibitors

A proton pump inhibitor containing a compound represented by the formula (I) wherein X and Y are the same or different and each is a bond or a spacer having 1 to 20 carbon atoms in the main chain, R 1 is an optionally substituted hydrocarbon group or an optionally substituted heterocyclic group, R 2 , R 3 and R 4 are the same or different and each is a hydrogen atom, an optionally substituted hydrocarbon group, an optionally substituted thienyl group, an optionally substituted benzo[b]thienyl group, an optionally substituted furyl group, an optionally substituted pyridyl group, an optionally substituted pyrazolyl group, an optionally substituted pyrimidinyl group, an acyl group, a halogen atom, a cyano group or a nitro group, R 5 and R 6 are the same or different and each is a hydrogen atom or an optionally substituted hydrocarbon group, which has a superior proton pump action and shows an antiulcer activity and the like after conversion to a proton pump inhibitor in the body, or a salt thereof. or a prodrug thereof is provided.